TP53 and myeloproliferative disorder: Other possible examples in eukaryotes are the common mutations in p53 that turn this tumor suppressor gene into a dominant transforming oncogene [32] and dominant gain-of-function mutations in JAK2 that result in myeloproliferative disorders [33].